Terveystalo Oyj

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, FSNUY has a market cap of 126.9B. Regarding current trading prices, TTALF is priced at $12.95, while FSNUY trades at $14.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas FSNUY's P/E ratio is 23.87. In terms of profitability, TTALF's ROE is +0.16%, compared to FSNUY's ROE of +0.06%. Regarding short-term risk, TTALF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check FSNUY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, FSNUF has a market cap of 31.7B. Regarding current trading prices, TTALF is priced at $12.95, while FSNUF trades at $56.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas FSNUF's P/E ratio is 23.98. In terms of profitability, TTALF's ROE is +0.16%, compared to FSNUF's ROE of +0.06%. Regarding short-term risk, TTALF is less volatile compared to FSNUF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check FSNUF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, JDHIF has a market cap of 26.5B. Regarding current trading prices, TTALF is priced at $12.95, while JDHIF trades at $8.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas JDHIF's P/E ratio is 39.50. In terms of profitability, TTALF's ROE is +0.16%, compared to JDHIF's ROE of +0.08%. Regarding short-term risk, TTALF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check JDHIF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, JDHIY has a market cap of 21.8B. Regarding current trading prices, TTALF is priced at $12.95, while JDHIY trades at $6.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas JDHIY's P/E ratio is 32.48. In terms of profitability, TTALF's ROE is +0.16%, compared to JDHIY's ROE of +0.08%. Regarding short-term risk, TTALF is less volatile compared to JDHIY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check JDHIY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, FMCQF has a market cap of 15B. Regarding current trading prices, TTALF is priced at $12.95, while FMCQF trades at $51.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas FMCQF's P/E ratio is 19.62. In terms of profitability, TTALF's ROE is +0.16%, compared to FMCQF's ROE of +0.05%. Regarding short-term risk, TTALF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check FMCQF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, TTALF is priced at $12.95, while BDUUY trades at $32.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, TTALF's ROE is +0.16%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, TTALF is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BDUUY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, IHHHF has a market cap of 10.5B. Regarding current trading prices, TTALF is priced at $12.95, while IHHHF trades at $1.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas IHHHF's P/E ratio is 17.00. In terms of profitability, TTALF's ROE is +0.16%, compared to IHHHF's ROE of +0.08%. Regarding short-term risk, TTALF and IHHHF have similar daily volatility (0.00).Check IHHHF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BDULF has a market cap of 9.9B. Regarding current trading prices, TTALF is priced at $12.95, while BDULF trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BDULF's P/E ratio is 20.71. In terms of profitability, TTALF's ROE is +0.16%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, TTALF is less volatile compared to BDULF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BDULF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BDUUF has a market cap of 9.4B. Regarding current trading prices, TTALF is priced at $12.95, while BDUUF trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BDUUF's P/E ratio is 19.67. In terms of profitability, TTALF's ROE is +0.16%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, TTALF is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BDUUF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, WFHG has a market cap of 6.7B. Regarding current trading prices, TTALF is priced at $12.95, while WFHG trades at $105.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas WFHG's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to WFHG's ROE of +0.28%. Regarding short-term risk, TTALF is less volatile compared to WFHG. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check WFHG's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RMSYF has a market cap of 5.9B. Regarding current trading prices, TTALF is priced at $12.95, while RMSYF trades at $25.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RMSYF's P/E ratio is 510.20. In terms of profitability, TTALF's ROE is +0.16%, compared to RMSYF's ROE of +0.01%. Regarding short-term risk, TTALF is less volatile compared to RMSYF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RMSYF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RMYHY has a market cap of 5.7B. Regarding current trading prices, TTALF is priced at $12.95, while RMYHY trades at $5.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RMYHY's P/E ratio is 571.00. In terms of profitability, TTALF's ROE is +0.16%, compared to RMYHY's ROE of +0.01%. Regarding short-term risk, TTALF and RMYHY have similar daily volatility (0.00).Check RMYHY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, TTALF is priced at $12.95, while ANHGY trades at $5.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, TTALF's ROE is +0.16%, compared to ANHGY's ROE of N/A. Regarding short-term risk, TTALF and ANHGY have similar daily volatility (0.00).Check ANHGY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BUHPF has a market cap of 3.9B. Regarding current trading prices, TTALF is priced at $12.95, while BUHPF trades at $4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BUHPF's P/E ratio is 17.96. In terms of profitability, TTALF's ROE is +0.16%, compared to BUHPF's ROE of +0.27%. Regarding short-term risk, TTALF is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BUHPF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BUGDF has a market cap of 3.4B. Regarding current trading prices, TTALF is priced at $12.95, while BUGDF trades at $4.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BUGDF's P/E ratio is 16.27. In terms of profitability, TTALF's ROE is +0.16%, compared to BUGDF's ROE of +0.27%. Regarding short-term risk, TTALF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BUGDF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MCVEF has a market cap of 3B. Regarding current trading prices, TTALF is priced at $12.95, while MCVEF trades at $19.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MCVEF's P/E ratio is 82.63. In terms of profitability, TTALF's ROE is +0.16%, compared to MCVEF's ROE of +0.09%. Regarding short-term risk, TTALF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check MCVEF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, TTALF is priced at $12.95, while ORPEF trades at $14.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, TTALF's ROE is +0.16%, compared to ORPEF's ROE of -0.23%. Regarding short-term risk, TTALF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check ORPEF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MCVEY has a market cap of 2.2B. Regarding current trading prices, TTALF is priced at $12.95, while MCVEY trades at $16.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, TTALF's ROE is +0.16%, compared to MCVEY's ROE of +0.09%. Regarding short-term risk, TTALF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check MCVEY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RAFLF has a market cap of 1.5B. Regarding current trading prices, TTALF is priced at $12.95, while RAFLF trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RAFLF's P/E ratio is 26.67. In terms of profitability, TTALF's ROE is +0.16%, compared to RAFLF's ROE of +0.03%. Regarding short-term risk, TTALF is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RAFLF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RHCGF has a market cap of 1.5B. Regarding current trading prices, TTALF is priced at $12.95, while RHCGF trades at $1.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RHCGF's P/E ratio is -3.99. In terms of profitability, TTALF's ROE is +0.16%, compared to RHCGF's ROE of -0.07%. Regarding short-term risk, TTALF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RHCGF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RYHTY has a market cap of 1.4B. Regarding current trading prices, TTALF is priced at $12.95, while RYHTY trades at $6.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RYHTY's P/E ratio is -3.86. In terms of profitability, TTALF's ROE is +0.16%, compared to RYHTY's ROE of -0.02%. Regarding short-term risk, TTALF and RYHTY have similar daily volatility (0.00).Check RYHTY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, LWSCF has a market cap of 1.2B. Regarding current trading prices, TTALF is priced at $12.95, while LWSCF trades at $13.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas LWSCF's P/E ratio is 46.71. In terms of profitability, TTALF's ROE is +0.16%, compared to LWSCF's ROE of +0.06%. Regarding short-term risk, TTALF and LWSCF have similar daily volatility (0.00).Check LWSCF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, LTGHY has a market cap of 1.1B. Regarding current trading prices, TTALF is priced at $12.95, while LTGHY trades at $3.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas LTGHY's P/E ratio is -20.67. In terms of profitability, TTALF's ROE is +0.16%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, TTALF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check LTGHY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, LTGHF has a market cap of 1.1B. Regarding current trading prices, TTALF is priced at $12.95, while LTGHF trades at $0.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas LTGHF's P/E ratio is -19.69. In terms of profitability, TTALF's ROE is +0.16%, compared to LTGHF's ROE of +0.40%. Regarding short-term risk, TTALF is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check LTGHF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, TTALF is priced at $12.95, while RHKJF trades at $15.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, TTALF's ROE is +0.16%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, TTALF is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RHKJF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RKAGY has a market cap of 986.6M. Regarding current trading prices, TTALF is priced at $12.95, while RKAGY trades at $7.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RKAGY's P/E ratio is 22.33. In terms of profitability, TTALF's ROE is +0.16%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, TTALF is less volatile compared to RKAGY. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RKAGY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NWKHY has a market cap of 961.4M. Regarding current trading prices, TTALF is priced at $12.95, while NWKHY trades at $7.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NWKHY's P/E ratio is 10.70. In terms of profitability, TTALF's ROE is +0.16%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, TTALF and NWKHY have similar daily volatility (0.00).Check NWKHY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, WHTCF has a market cap of 901.2M. Regarding current trading prices, TTALF is priced at $12.95, while WHTCF trades at $3.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas WHTCF's P/E ratio is -10.17. In terms of profitability, TTALF's ROE is +0.16%, compared to WHTCF's ROE of -0.15%. Regarding short-term risk, TTALF is less volatile compared to WHTCF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check WHTCF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, EXETF has a market cap of 805.5M. Regarding current trading prices, TTALF is priced at $12.95, while EXETF trades at $9.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas EXETF's P/E ratio is 13.73. In terms of profitability, TTALF's ROE is +0.16%, compared to EXETF's ROE of +0.65%. Regarding short-term risk, TTALF and EXETF have similar daily volatility (0.00).Check EXETF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, JXFGF has a market cap of 755.6M. Regarding current trading prices, TTALF is priced at $12.95, while JXFGF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, TTALF's ROE is +0.16%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, TTALF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check JXFGF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, TTALF is priced at $12.95, while KDGTF trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, TTALF's ROE is +0.16%, compared to KDGTF's ROE of N/A. Regarding short-term risk, TTALF and KDGTF have similar daily volatility (0.00).Check KDGTF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, TTALF is priced at $12.95, while ORRRY trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, TTALF's ROE is +0.16%, compared to ORRRY's ROE of +7.04%. Regarding short-term risk, TTALF and ORRRY have similar daily volatility (0.00).Check ORRRY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, TTALF is priced at $12.95, while BTMDW trades at $1.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, TTALF's ROE is +0.16%, compared to BTMDW's ROE of -0.31%. Regarding short-term risk, TTALF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BTMDW's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, EVGRF has a market cap of 236M. Regarding current trading prices, TTALF is priced at $12.95, while EVGRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas EVGRF's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to EVGRF's ROE of +0.21%. Regarding short-term risk, TTALF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check EVGRF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, TTALF is priced at $12.95, while MKLNF trades at $11.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, TTALF's ROE is +0.16%, compared to MKLNF's ROE of +0.14%. Regarding short-term risk, TTALF and MKLNF have similar daily volatility (0.00).Check MKLNF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MFCSF has a market cap of 198.6M. Regarding current trading prices, TTALF is priced at $12.95, while MFCSF trades at $10.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MFCSF's P/E ratio is 5.66. In terms of profitability, TTALF's ROE is +0.16%, compared to MFCSF's ROE of +0.90%. Regarding short-term risk, TTALF and MFCSF have similar daily volatility (0.00).Check MFCSF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, CHHHF has a market cap of 135M. Regarding current trading prices, TTALF is priced at $12.95, while CHHHF trades at $2.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas CHHHF's P/E ratio is -107.00. In terms of profitability, TTALF's ROE is +0.16%, compared to CHHHF's ROE of -0.02%. Regarding short-term risk, TTALF is less volatile compared to CHHHF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check CHHHF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, COLRF has a market cap of 123M. Regarding current trading prices, TTALF is priced at $12.95, while COLRF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas COLRF's P/E ratio is -8.00. In terms of profitability, TTALF's ROE is +0.16%, compared to COLRF's ROE of +0.01%. Regarding short-term risk, TTALF is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check COLRF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, VTIAF has a market cap of 95.9M. Regarding current trading prices, TTALF is priced at $12.95, while VTIAF trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas VTIAF's P/E ratio is -6.87. In terms of profitability, TTALF's ROE is +0.16%, compared to VTIAF's ROE of -0.63%. Regarding short-term risk, TTALF is less volatile compared to VTIAF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check VTIAF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, TTALF is priced at $12.95, while MCIOF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, TTALF's ROE is +0.16%, compared to MCIOF's ROE of N/A. Regarding short-term risk, TTALF and MCIOF have similar daily volatility (0.00).Check MCIOF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, TTALF is priced at $12.95, while ASSF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ASSF's P/E ratio is -33.33. In terms of profitability, TTALF's ROE is +0.16%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, TTALF and ASSF have similar daily volatility (0.00).Check ASSF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, KONEF has a market cap of 44.3M. Regarding current trading prices, TTALF is priced at $12.95, while KONEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas KONEF's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, TTALF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check KONEF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, TTALF is priced at $12.95, while USNU trades at $1.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas USNU's P/E ratio is -9.41. In terms of profitability, TTALF's ROE is +0.16%, compared to USNU's ROE of -0.55%. Regarding short-term risk, TTALF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check USNU's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NVLPF has a market cap of 20.8M. Regarding current trading prices, TTALF is priced at $12.95, while NVLPF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NVLPF's P/E ratio is 23.82. In terms of profitability, TTALF's ROE is +0.16%, compared to NVLPF's ROE of +0.01%. Regarding short-term risk, TTALF and NVLPF have similar daily volatility (0.00).Check NVLPF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, TTALF is priced at $12.95, while HQDA trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas HQDA's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, TTALF and HQDA have similar daily volatility (0.00).Check HQDA's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, TTALF is priced at $12.95, while FPCG trades at $1,025.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas FPCG's P/E ratio is 0.09. In terms of profitability, TTALF's ROE is +0.16%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, TTALF and FPCG have similar daily volatility (0.00).Check FPCG's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NUMIF has a market cap of 9.9M. Regarding current trading prices, TTALF is priced at $12.95, while NUMIF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NUMIF's P/E ratio is -1.03. In terms of profitability, TTALF's ROE is +0.16%, compared to NUMIF's ROE of -2.96%. Regarding short-term risk, TTALF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check NUMIF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, HLYK has a market cap of 7.9M. Regarding current trading prices, TTALF is priced at $12.95, while HLYK trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas HLYK's P/E ratio is -1.39. In terms of profitability, TTALF's ROE is +0.16%, compared to HLYK's ROE of +1.42%. Regarding short-term risk, TTALF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check HLYK's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, GBCS has a market cap of 7.7M. Regarding current trading prices, TTALF is priced at $12.95, while GBCS trades at $2.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas GBCS's P/E ratio is -2.40. In terms of profitability, TTALF's ROE is +0.16%, compared to GBCS's ROE of +0.55%. Regarding short-term risk, TTALF is less volatile compared to GBCS. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check GBCS's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, XCRT has a market cap of 6.8M. Regarding current trading prices, TTALF is priced at $12.95, while XCRT trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas XCRT's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to XCRT's ROE of +0.90%. Regarding short-term risk, TTALF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check XCRT's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BICX has a market cap of 6.3M. Regarding current trading prices, TTALF is priced at $12.95, while BICX trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BICX's P/E ratio is -1.00. In terms of profitability, TTALF's ROE is +0.16%, compared to BICX's ROE of +0.39%. Regarding short-term risk, TTALF and BICX have similar daily volatility (0.00).Check BICX's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, VLXC has a market cap of 5.7M. Regarding current trading prices, TTALF is priced at $12.95, while VLXC trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas VLXC's P/E ratio is -8.00. In terms of profitability, TTALF's ROE is +0.16%, compared to VLXC's ROE of +0.58%. Regarding short-term risk, TTALF is less volatile compared to VLXC. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check VLXC's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RVLWF has a market cap of 5.3M. Regarding current trading prices, TTALF is priced at $12.95, while RVLWF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, TTALF's ROE is +0.16%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, TTALF and RVLWF have similar daily volatility (0.00).Check RVLWF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, RHEP has a market cap of 3.9M. Regarding current trading prices, TTALF is priced at $12.95, while RHEP trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas RHEP's P/E ratio is -0.76. In terms of profitability, TTALF's ROE is +0.16%, compared to RHEP's ROE of +1.14%. Regarding short-term risk, TTALF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check RHEP's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, TTALF is priced at $12.95, while EPWCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, TTALF's ROE is +0.16%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check EPWCF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, GRST has a market cap of 2.3M. Regarding current trading prices, TTALF is priced at $12.95, while GRST trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas GRST's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to GRST's ROE of +0.28%. Regarding short-term risk, TTALF and GRST have similar daily volatility (0.00).Check GRST's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, TOKIF has a market cap of 1.8M. Regarding current trading prices, TTALF is priced at $12.95, while TOKIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, TTALF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check TOKIF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, TTALF is priced at $12.95, while SMAS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas SMAS's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to SMAS's ROE of N/A. Regarding short-term risk, TTALF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check SMAS's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, TTALF is priced at $12.95, while MDGP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MDGP's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, TTALF and MDGP have similar daily volatility (0.00).Check MDGP's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, TTALF is priced at $12.95, while NOVC trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NOVC's P/E ratio is -0.20. In terms of profitability, TTALF's ROE is +0.16%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, TTALF and NOVC have similar daily volatility (0.00).Check NOVC's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, TTALF is priced at $12.95, while PHMB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas PHMB's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to PHMB's ROE of N/A. Regarding short-term risk, TTALF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check PHMB's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, JNHMF has a market cap of 870.6K. Regarding current trading prices, TTALF is priced at $12.95, while JNHMF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas JNHMF's P/E ratio is -0.17. In terms of profitability, TTALF's ROE is +0.16%, compared to JNHMF's ROE of +0.47%. Regarding short-term risk, TTALF is less volatile compared to JNHMF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check JNHMF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, TTALF is priced at $12.95, while GNOW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas GNOW's P/E ratio is -0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, TTALF and GNOW have similar daily volatility (0.00).Check GNOW's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ERUC has a market cap of 638.1K. Regarding current trading prices, TTALF is priced at $12.95, while ERUC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ERUC's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to ERUC's ROE of N/A. Regarding short-term risk, TTALF and ERUC have similar daily volatility (0.00).Check ERUC's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, JRSS has a market cap of 507.6K. Regarding current trading prices, TTALF is priced at $12.95, while JRSS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas JRSS's P/E ratio is -0.06. In terms of profitability, TTALF's ROE is +0.16%, compared to JRSS's ROE of +1.88%. Regarding short-term risk, TTALF is less volatile compared to JRSS. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check JRSS's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, DPAT has a market cap of 481.6K. Regarding current trading prices, TTALF is priced at $12.95, while DPAT trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas DPAT's P/E ratio is -2.00. In terms of profitability, TTALF's ROE is +0.16%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, TTALF and DPAT have similar daily volatility (0.00).Check DPAT's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, TTALF is priced at $12.95, while MSITF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MSITF's P/E ratio is -0.10. In terms of profitability, TTALF's ROE is +0.16%, compared to MSITF's ROE of N/A. Regarding short-term risk, TTALF is less volatile compared to MSITF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check MSITF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, FCHS has a market cap of 395.5K. Regarding current trading prices, TTALF is priced at $12.95, while FCHS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas FCHS's P/E ratio is -0.13. In terms of profitability, TTALF's ROE is +0.16%, compared to FCHS's ROE of +0.08%. Regarding short-term risk, TTALF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check FCHS's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, KJFI has a market cap of 374.6K. Regarding current trading prices, TTALF is priced at $12.95, while KJFI trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas KJFI's P/E ratio is -0.06. In terms of profitability, TTALF's ROE is +0.16%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to KJFI. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check KJFI's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, TTALF is priced at $12.95, while ARPC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ARPC's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to ARPC's ROE of +3.10%. Regarding short-term risk, TTALF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check ARPC's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NXGT has a market cap of 332.9K. Regarding current trading prices, TTALF is priced at $12.95, while NXGT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NXGT's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to NXGT's ROE of +0.06%. Regarding short-term risk, TTALF is less volatile compared to NXGT. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check NXGT's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, TTALF is priced at $12.95, while BNYN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BNYN's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, TTALF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check BNYN's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, DRWN has a market cap of 239.8K. Regarding current trading prices, TTALF is priced at $12.95, while DRWN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas DRWN's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, TTALF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check DRWN's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, SETO has a market cap of 160.9K. Regarding current trading prices, TTALF is priced at $12.95, while SETO trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas SETO's P/E ratio is -1.29. In terms of profitability, TTALF's ROE is +0.16%, compared to SETO's ROE of +0.00%. Regarding short-term risk, TTALF and SETO have similar daily volatility (0.00).Check SETO's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, TTALF is priced at $12.95, while TPIA trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas TPIA's P/E ratio is -0.15. In terms of profitability, TTALF's ROE is +0.16%, compared to TPIA's ROE of +0.60%. Regarding short-term risk, TTALF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check TPIA's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, TTALF is priced at $12.95, while AMBD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas AMBD's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, TTALF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check AMBD's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, TTALF is priced at $12.95, while NMHLY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, TTALF's ROE is +0.16%, compared to NMHLY's ROE of N/A. Regarding short-term risk, TTALF and NMHLY have similar daily volatility (0.00).Check NMHLY's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, CLRD has a market cap of 32.5K. Regarding current trading prices, TTALF is priced at $12.95, while CLRD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas CLRD's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, TTALF is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check CLRD's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, HSMD has a market cap of 19.2K. Regarding current trading prices, TTALF is priced at $12.95, while HSMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas HSMD's P/E ratio is -0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, TTALF and HSMD have similar daily volatility (0.00).Check HSMD's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, TTALF is priced at $12.95, while SCAL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas SCAL's P/E ratio is 0.04. In terms of profitability, TTALF's ROE is +0.16%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, TTALF and SCAL have similar daily volatility (0.00).Check SCAL's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, CEVE has a market cap of 15.4K. Regarding current trading prices, TTALF is priced at $12.95, while CEVE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas CEVE's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, TTALF and CEVE have similar daily volatility (0.00).Check CEVE's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, TTALF is priced at $12.95, while GENN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas GENN's P/E ratio is -0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to GENN's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check GENN's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, TTALF is priced at $12.95, while CHCR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas CHCR's P/E ratio is -0.00. In terms of profitability, TTALF's ROE is +0.16%, compared to CHCR's ROE of N/A. Regarding short-term risk, TTALF and CHCR have similar daily volatility (0.00).Check CHCR's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, TTALF is priced at $12.95, while ACGI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas ACGI's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, TTALF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check ACGI's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NRTSF has a market cap of 7.8K. Regarding current trading prices, TTALF is priced at $12.95, while NRTSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NRTSF's P/E ratio is 0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to NRTSF's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to NRTSF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check NRTSF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NAFS has a market cap of 7K. Regarding current trading prices, TTALF is priced at $12.95, while NAFS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NAFS's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, TTALF and NAFS have similar daily volatility (0.00).Check NAFS's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, PRMD has a market cap of 5.6K. Regarding current trading prices, TTALF is priced at $12.95, while PRMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas PRMD's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, TTALF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check PRMD's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, TTALF is priced at $12.95, while MSGP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MSGP's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, TTALF and MSGP have similar daily volatility (0.00).Check MSGP's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, TTALF is priced at $12.95, while SLHPF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas SLHPF's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check SLHPF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, TTALF is priced at $12.95, while WEQL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas WEQL's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, TTALF and WEQL have similar daily volatility (0.00).Check WEQL's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, TTALF is priced at $12.95, while BBAL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BBAL's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, TTALF and BBAL have similar daily volatility (0.00).Check BBAL's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, PAOG has a market cap of 2.5K. Regarding current trading prices, TTALF is priced at $12.95, while PAOG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas PAOG's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to PAOG's ROE of +0.05%. Regarding short-term risk, TTALF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check PAOG's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, TTALF is priced at $12.95, while NMMCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, TTALF's ROE is +0.16%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, TTALF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check NMMCF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, TTALF is priced at $12.95, while PPRG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas PPRG's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, TTALF and PPRG have similar daily volatility (0.00).Check PPRG's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, TTALF is priced at $12.95, while OHAQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, TTALF's ROE is +0.16%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, TTALF and OHAQ have similar daily volatility (0.00).Check OHAQ's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, TTALF is priced at $12.95, while BNKL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas BNKL's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, TTALF and BNKL have similar daily volatility (0.00).Check BNKL's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, TTALF is priced at $12.95, while MAHN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas MAHN's P/E ratio is 0.05. In terms of profitability, TTALF's ROE is +0.16%, compared to MAHN's ROE of N/A. Regarding short-term risk, TTALF is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for TTALF.Check MAHN's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, SLHGF has a market cap of 398. Regarding current trading prices, TTALF is priced at $12.95, while SLHGF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas SLHGF's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, TTALF and SLHGF have similar daily volatility (0.00).Check SLHGF's competition here

TTALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TTALF stands at 1.6B. In comparison, NMSCA has a market cap of 275. Regarding current trading prices, TTALF is priced at $12.95, while NMSCA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TTALF currently has a P/E ratio of 19.33, whereas NMSCA's P/E ratio is N/A. In terms of profitability, TTALF's ROE is +0.16%, compared to NMSCA's ROE of +0.02%. Regarding short-term risk, TTALF and NMSCA have similar daily volatility (0.00).Check NMSCA's competition here